Clinical Trials List
2026-01-26 - 2031-01-31
Phase II
Not yet recruiting2
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-10N06.9
Isolated proteinuria with unspecified morphologic lesion
ICD-10N07.9
Hereditary nephropathy, not elsewhere classified with unspecified morphologic lesions
ICD-10N15.9
Renal tubulo-interstitial disease, unspecified
ICD-9583.9
Nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林維洲 Division of General Internal Medicine
- 陳怡婷 Division of General Internal Medicine
- CHUN-FU LAI Division of General Internal Medicine
- SHUEI-LIONG LIN Division of General Internal Medicine
- YU-HSIANG CHOU Division of General Internal Medicine
- 楊紹佑 Division of General Internal Medicine
- 潘思宇 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2-6 participants
-
Global
32 participants
